0519 Variant Bio ECP
BioCentury & Getty Images

Emerging Company Profile

Variant Bio: creating a new social contract for genome-based drug discovery

Emerging Company Profile: Variant Bio aims to turn insights from indigenous communities into medicines for all

Variant Bio aims to turn insights from indigenous communities into medicines for all.

May 19, 2021 | 11:58 PM GMT

Variant Bio aims to develop drugs based on data gathered in collaboration with groups that have maintained genetic and often cultural distance from the populations that dominate genomic databases.

The DNA of genetically distinct populations is one of the most promising places to look for insights that could lead to the development of transformational medicines, but the search requires cultural sensitivity and long-term engagement with communities that are unfamiliar to most biotech companies.

One measure of Variant

Read the full 1293 word article

How to gain access

Continue reading with a
two-week free trial.